Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 537: | Line 537: | ||
!Associated findings | !Associated findings | ||
|- | |- | ||
! rowspan="4" | | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rheumatologic/autoimmune disorders | ||
!Immune thrombocytopenia | !Immune thrombocytopenia | ||
! | ! | ||
Line 662: | Line 662: | ||
! | ! | ||
|- | |- | ||
! rowspan="7" |Infection-induced | ! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection-induced | ||
! rowspan="3" align="center" style="background:#DCDCDC;" + |Bacterial infections | ! rowspan="3" align="center" style="background:#DCDCDC;" + |Bacterial infections | ||
! align="center" style="background:#DCDCDC;" + |Sepsis | ! align="center" style="background:#DCDCDC;" + |Sepsis | ||
Line 911: | Line 911: | ||
!Associated findings | !Associated findings | ||
|- | |- | ||
! rowspan="5" |Medication/toxicity | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medication/toxicity | ||
! align="center" style="background:#DCDCDC;" + |Drug-induced immune thrombocytopenia | ! align="center" style="background:#DCDCDC;" + |Drug-induced immune thrombocytopenia | ||
! | ! | ||
Line 984: | Line 984: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | !Cytotoxic chemotherapy | ||
! | ! | ||
| | | | ||
Line 1,077: | Line 1,077: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! rowspan="2" |GI | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI | ||
!Chronic liver disease | !Chronic liver disease | ||
! | ! | ||
Line 1,172: | Line 1,172: | ||
!Associated findings | !Associated findings | ||
|- | |- | ||
! rowspan="3" |Vascular | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vascular | ||
!Giant capillary hemangioma | !Giant capillary hemangioma | ||
! | ! | ||
Line 1,266: | Line 1,266: | ||
! | ! | ||
|- | |- | ||
! rowspan="3" |Other | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
!Alcohol | !Alcohol | ||
! | ! |
Revision as of 21:53, 14 August 2018
Thrombocytopenia Differential Diagnosis
Differentiating the diseases that can cause thrombocytopenia:
Category | Condition | Mechanism | Mechanism | Inherited | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age range | History | Symptoms | Signs | |||||||||||||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||||||||||||||
Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | BT | UA | ||||||||||||||||
Decreased platelet production | Platelet destruction in bloodstream | Platelet destruction in spleen/liver | Plt | HB | WBC | |||||||||||||||||||||||||
Hematology | Bone marrow disorders | Myelodysplastic syndromes | + | |||||||||||||||||||||||||||
Aplastic anemia | + | |||||||||||||||||||||||||||||
Acute leukemia | + | |||||||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria (PNH) | + | Diagnosis of exclusion | ||||||||||||||||||||||||||||
Thrombotic microangiopathy (TMA) | Thrombotic thrombocytopenic purpura (TTP) | + | ||||||||||||||||||||||||||||
Hemolytic uremic syndrome (HUS) | + | |||||||||||||||||||||||||||||
DIC | ||||||||||||||||||||||||||||||
Congenital platelet disorders | MYH-9 related disorders | |||||||||||||||||||||||||||||
Bernard-Soulier syndrome | ||||||||||||||||||||||||||||||
Gray platelet syndrome | ||||||||||||||||||||||||||||||
Wiskott-Aldrich syndrome | ||||||||||||||||||||||||||||||
Thrombocytopenia with absent radius (TAR) syndrome | ||||||||||||||||||||||||||||||
Alport syndrome | ||||||||||||||||||||||||||||||
Von Willebrand disease | ||||||||||||||||||||||||||||||
Nutrient deficiencies | Folate, vitamin B12, copper | an autoimmune mechanism | + | |||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in bloodstream | Platelet destruction in spleen/liver | Inherited | Acquried | Age range | History | Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | BT | UA | Imaging | Gold standard | Associated findings | |
Rheumatologic/autoimmune disorders | Immune thrombocytopenia | Antibody-mediated platelet destruction | + | Moderate to severe | - | |||||||||||||||||||||||||
Systemic lupus erythematosus (SLE) | ||||||||||||||||||||||||||||||
Antiphospholipid syndrome (APS) | autoantibody-mediated syndrome | |||||||||||||||||||||||||||||
Felty's syndrome | splenomegaly | |||||||||||||||||||||||||||||
Infection-induced | Bacterial infections | Sepsis | Direct bone marrow suppression | + | + | |||||||||||||||||||||||||
Helicobacter pylori | Immune thrombocytopenia | + | ||||||||||||||||||||||||||||
Tick-borne infection | + | |||||||||||||||||||||||||||||
Viral infections | HIV |
|
+ | |||||||||||||||||||||||||||
Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus | + | |||||||||||||||||||||||||||||
Intracellular parasites | Malaria | |||||||||||||||||||||||||||||
Babesiosis | ||||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in bloodstream | Platelet destruction in spleen/liver | Inherited | Acquried | Age range | History | Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | BT | UA | Imaging | Gold standard | Associated findings | |
Medication/toxicity | Drug-induced immune thrombocytopenia |
|
Occurrence of drug-dependent, platelet-reactive antibodies | + | ||||||||||||||||||||||||||
Heparin-induced thrombocytopenia | + | |||||||||||||||||||||||||||||
Cytotoxic chemotherapy | + | |||||||||||||||||||||||||||||
Radiation therapy | Predictable, dose-dependent myelosuppression | + | ||||||||||||||||||||||||||||
OTC agents | Quinine-containing beverages | |||||||||||||||||||||||||||||
GI | Chronic liver disease | + | Mild | |||||||||||||||||||||||||||
Portal hypertension | ||||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in bloodstream | Platelet destruction in spleen/liver | Inherited | Acquried | Age range | History | Severity | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | BT | UA | Imaging | Gold standard | Associated findings | |
Vascular | Giant capillary hemangioma | platelet destruction | + | |||||||||||||||||||||||||||
Aortic aneurysm | platelet destruction | + | ||||||||||||||||||||||||||||
Cardiopulmonary bypass | platelet destruction | + | ||||||||||||||||||||||||||||
Other | Alcohol | + | ||||||||||||||||||||||||||||
Post-transfusion purpura | immune-mediated platelet destruction | |||||||||||||||||||||||||||||
Gestational thrombocytopenia | + |